Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New supplement promises sharper mind and stronger workout in just 16 days

NCT ID NCT06374641

Symptom relief Sponsor: University of Exeter Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether taking a new supplement for 16 days could improve exercise performance and cognitive function in 40 healthy adults (20 young, 20 older). Participants completed cognitive tests, cycling exercises, and blood tests. The supplement was compared to a placebo to see if it truly made a difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Mar 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants will be deemed eligible to participate provided they are willing and able to follow the study instructions and 1. are able to take part in intense exercise (as assessed via Physical Activity Readiness Questionnaire (PARQ)) 2. are able to consume a dietary supplement 3. are not overweight/obese (assessed by BMI) 4. do not have any cardiovascular, respiratory, metabolic or musculoskeletal disorders, or any other contraindication to the performance of maximal exercise. Exclusion Criteria: 1. Aged 31-49 and aged 66+. 2. underlying illness or injury (assessed via PARQ) 3. overweight or obese individuals (BMI of \>30 kg.m-2). 4. Cardiovascular, respiratory, metabolic or musculoskeletal disorders (assessed by screening form). 5. Use of dietary supplements, tobacco smoking. 6. Pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive function are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognitive function Exercise performance

Contacts and locations

Locations

  • Richards Building St. Lukes Campus University of Exeter

    Exeter, Devon, EX2 4TH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.